Chronic Inflammation and Aging in Rheumatic Diseases

Area of Science:

• Gerontology
• Immunology
• Rheumatology

Background:

• Cellular senescence and immunosenescence contribute to chronic inflammation and tissue damage.
• The senescence-associated secretory phenotype (SASP) releases pro-inflammatory cytokines (IL-6, IL-1β, TNF-α).
• In osteoarthritis (OA) and rheumatoid arthritis (RA), senescent cells exacerbate disease pathology.

Purpose of the Study:

• To review the role of cellular senescence and immunosenescence in age-related rheumatic diseases.
• To discuss the impact of SASP-mediated inflammation in OA and RA.
• To highlight emerging therapeutic strategies targeting aging mechanisms.

Main Methods:

• Literature review of cellular senescence, immunosenescence, and SASP in rheumatic diseases.
• Analysis of the role of pro-inflammatory cytokines in OA and RA pathogenesis.
• Evaluation of senolytics and cytokine inhibitors as therapeutic interventions.

Main Results:

• Senescent cells and SASP drive chronic inflammation in rheumatic diseases.
• Senescent chondrocytes in OA promote cartilage degradation.
• Aged immune cells in RA impair self-tolerance, worsening the disease.
• Senolytics and cytokine inhibitors show potential in preclinical studies.

Conclusions:

• Combined anti-aging and anti-inflammatory strategies are crucial for managing age-related rheumatic diseases.
• Targeting cellular senescence and SASP offers a novel therapeutic avenue.
• Further research into senolytics and cytokine inhibitors is warranted for OA and RA treatment.